Jade Biosciences, Inc. Common Stock JBIO Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Liquidity | ||||||
| Current ratio | 14.3×-6.8× | 21.1×+12.1× | 9×-1.3× | 10.3×-21.7× | 32×+26.2× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×— | —— | |
| Per Share | ||||||
| Book value per share | $5.13-51.6% | $10.60+134% | $4.53-36.1% | $7.09+127% | -$26.46-78.4% | |
| Valuation | ||||||
| Market capitalization | $1.33B+318% | $760.92M+170% | $281.57M-16.7% | $337.83M— | —— | |
| Price / book | 4.5×— | 2.3×+0.7× | 1.6×-0.1× | 1.7×— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Jade Biosciences, Inc. Common Stock's ratios come from?
- Every ratio is computed from Jade Biosciences, Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.